Burgeoning Demand for Scoring Balloon Catheter Promises Higher Revenue Share Steered by Increased Manufacturer Support, details Fact.MR study

The global scoring balloon catheter market is predicted to reflect a sluggish growth attributed to increasing risk of infection and artery collapse. Scoring balloon catheter devices witness a steady demand among the healthcare professionals globally. Increasing preference for scoring balloon catheters over conventional catheters attributed to limited features in the healthcare industry will fuel growth of the global market. Hospitals will witness steady growth in terms of consumption in the global market during the predicted period. Polyurethane will register the highest revenue growth in the global scoring balloon catheter market by the end of 2017. Coronary artery disease in terms of disease indication is expected to generate significant revenue in the global market in 2017.

Download sample copy of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=148

Scoring Balloon Catheters are used for dialysis of renal and peripheral vascular diseases. These devices also witness a considerable demand among the healthcare professionals due to growing need for coronary artery diseases. Scoring balloon catheters witness more preference as compared to the conventional catheters attributed to uncontrolled dissection including insufficient luminal expansion.

According to Fact.MR’s forecast, the global scoring balloon catheter market is expected to register a slow CAGR, and will represent a value of more than US$ 200 Mn by the end of 2022.

Consumption in Healthcare Industry

Equipped with enhanced technology, scoring balloon catheters have brought respite to the patients of coronary artery disease. Despite increasing risks of artery collapse during the catheterization process, the scoring balloon catheters is expected to witness considerable demand in the healthcare sector. Conventional balloons are bound to limitations including insufficient luminal expansion and bailout stenting due to uncontrolled dissection. Scoring technology enables superior luminal expansion through re-expansion of original stent and effective mechanical dilatation of the neointimal tissue. Attributed to benefits of treating ISR without slippage, the scoring balloon catheters are more preferred over the conventional devices in the healthcare industry.

Preference over Conventional Devices

Moreover, insufficient luminal expansion during treatment of fibrocalcific lesion through conventional devices and resistance to the dilatation has led manufacturers to adopt scoring technology for production of balloon catheters. Conventional balloons are bound to lower patency rate and repetitive revascularization. Due to such factors, the scoring balloon catheters are more preferred during the treatment process as compared to the conventional devices.

However, growing risk artery collapse attributed to catheterization process is predicted to hinder growth of the global scoring balloon catheter by the end of 2022. Moreover, increasing risk of infections due to catheterization treatment is expected to pose challenges for the global market of scoring balloon catheters. Such factors are likely to impact growth of the global scoring balloon catheter market negatively during the predicted period.

Hospitals to Remain a Leading Segment

Coronary artery diseases is expected to witness the highest growth in terms of revenue in the global market. This segment is predicted to register the highest CAGR in APEJ. Coronary artery diseases will represent a value of nearly US$ 40 Mn in 2017. Peripheral vascular disease as compared to other disease indication is expected to represent the second highest revenue growth in the global scoring balloon market.

Hospitals is expected to represent the highest revenue growth in the global scoring balloon market by the end of 2022. Europe is predicted to represent the largest market share globally during the predicted period. Cardiac catheterization laboratories is expected to represent the second highest revenue growth in the global scoring balloon catheter market by 2022 – end. This segment is expected to register the highest CAGR growth in the global scoring balloon catheter market through 2022.

Polyurethane is predicted to register the highest CAGR as compared to the other raw materials in the global scoring balloon catheter market through 2022. In terms of revenue, nylon is expected to represent the highest growth in the global market. This segment is predicted to represent a value of over US$ 30 Mn in 2017. North America is expected to remain the largest market for nylon among other raw materials globally through 2022.

Market Players

Major market players operating in the global scoring balloon catheter market include Medtronic Plc, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Tokai Medical Products Inc., Boston Scientific Corporation, Terumo Corporation, MicroPort Scientific Corporation, Jotech GmbH, Meril Life Sciences Pvt Ltd, Hexacath, Abbott Laboratories, Cordis Corporation, Cook Medical INC, and Cardionovum GmbH.

Inquire about this Report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=148

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us            
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at – https://www.industrynewsanalysis.com/

Matched content

Editor’s pick